- Drug Coverage
- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Safety & Recalls
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
The value of Innovative Medicine: The clinical and economic impact of the first gene therapy for hemophilia B
Content provided by CSL Behring. Copyright 2023 and published by MJH Life Sciences®. No portion of this program may be reproduced or transmitted in any form, by any means, without the prior written permission of MJH Life Sciences. The views and opinions expressed in this material do not necessarily reflect the views and opinions of MJH Life Sciences, or Managed Healthcare Executive®.
Advertorial: The value of Innovative Medicine. The clinical and economic impact of the first gene therapy for hemophilia B
LTACHs vs. SNFs: What's the Difference?
April 3rd 2024The unique expertise and resources available at long-term acute care hospitals (LTACHs) allows them to provide efficient care for medically complex patients. Discover 5 key differences between LTACHs and skilled nursing facilities (SNFs) that impact patient outcomes.
Read More
Transforming the management of genetic testing
March 15th 2024This report will explain where the current genetic test management system is inadequate and how a new approach designed specifically for genetic testing will perform better and provide more meaningful and actionable results.
Read More
